PL334337A1 - Derivatives of sulphonamides, method of obtaining them and their application as drugs - Google Patents
Derivatives of sulphonamides, method of obtaining them and their application as drugsInfo
- Publication number
- PL334337A1 PL334337A1 PL97334337A PL33433797A PL334337A1 PL 334337 A1 PL334337 A1 PL 334337A1 PL 97334337 A PL97334337 A PL 97334337A PL 33433797 A PL33433797 A PL 33433797A PL 334337 A1 PL334337 A1 PL 334337A1
- Authority
- PL
- Poland
- Prior art keywords
- sulphonamides
- drugs
- derivatives
- obtaining
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9626377.7A GB9626377D0 (en) | 1996-12-19 | 1996-12-19 | Novel compounds |
GBGB9700901.3A GB9700901D0 (en) | 1997-01-17 | 1997-01-17 | Novel compounds |
GBGB9722757.3A GB9722757D0 (en) | 1997-10-27 | 1997-10-27 | Novel compounds |
PCT/EP1997/007159 WO1998027081A1 (en) | 1996-12-19 | 1997-12-15 | Sulphonamide derivatives, process for their preparation, and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PL334337A1 true PL334337A1 (en) | 2000-02-28 |
Family
ID=27268644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL97334337A PL334337A1 (en) | 1996-12-19 | 1997-12-15 | Derivatives of sulphonamides, method of obtaining them and their application as drugs |
Country Status (31)
Country | Link |
---|---|
US (2) | US6423717B1 (en) |
EP (1) | EP0946539B1 (en) |
JP (1) | JP2001506646A (en) |
KR (1) | KR20000069554A (en) |
CN (1) | CN1246116A (en) |
AP (1) | AP1277A (en) |
AR (1) | AR010795A1 (en) |
AT (1) | ATE247099T1 (en) |
AU (1) | AU729056B2 (en) |
BG (1) | BG103530A (en) |
BR (1) | BR9713734A (en) |
CA (1) | CA2275492A1 (en) |
CZ (1) | CZ220399A3 (en) |
DE (1) | DE69724142T2 (en) |
DZ (1) | DZ2376A1 (en) |
EA (1) | EA002351B1 (en) |
ES (1) | ES2203831T3 (en) |
HU (1) | HUP0000658A3 (en) |
ID (1) | ID22821A (en) |
IL (1) | IL130297A0 (en) |
MA (1) | MA24426A1 (en) |
NO (1) | NO993003D0 (en) |
NZ (1) | NZ335970A (en) |
OA (1) | OA11066A (en) |
PE (1) | PE46899A1 (en) |
PL (1) | PL334337A1 (en) |
SK (1) | SK80899A3 (en) |
TR (1) | TR199901361T2 (en) |
TW (1) | TW418205B (en) |
UY (1) | UY24819A1 (en) |
WO (1) | WO1998027081A1 (en) |
Families Citing this family (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2376A1 (en) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them. |
IL133870A0 (en) * | 1997-07-11 | 2001-04-30 | Smithkline Beecham Plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
AU759255B2 (en) | 1998-01-29 | 2003-04-10 | Amgen, Inc. | PPAR-gamma modulators |
GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
US6194410B1 (en) | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
GB9810671D0 (en) * | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
GB9818914D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
GB9820113D0 (en) | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
GB9926302D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
WO2001045694A1 (en) * | 1999-12-21 | 2001-06-28 | Smithkline Beecham Corporation | Urotensin-ii receptor antagonists |
SE9904723D0 (en) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
SE0001899D0 (en) | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
US6818639B2 (en) | 2000-07-21 | 2004-11-16 | Biovitrum Ab | Pharmaceutical combination formulation and method of treatment with the combination |
US6399617B1 (en) | 2000-07-21 | 2002-06-04 | Biovitrum Ab | Use |
SE0002754D0 (en) * | 2000-07-21 | 2000-07-21 | Pharmacia & Upjohn Ab | New pharmaceutical combination formulation and method of treatment with the combination |
SE0002739D0 (en) * | 2000-07-21 | 2000-07-21 | Pharmacia & Upjohn Ab | New use |
US7071220B2 (en) | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
CA2422807C (en) * | 2000-09-18 | 2009-12-08 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
EP1341783A1 (en) | 2000-11-21 | 2003-09-10 | Smithkline Beecham Plc | Isoquinoline derivatives useful in the treatment of cns disorders |
CA2432713C (en) | 2000-12-22 | 2009-10-27 | Ishihara Sangyo Kaisha, Ltd. | Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
JP2004534017A (en) * | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | BACE inhibitors |
WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
JP2004535390A (en) * | 2001-05-07 | 2004-11-25 | スミスクライン・ビーチャム・コーポレイション | Sulfonamide |
JP2004529168A (en) * | 2001-05-07 | 2004-09-24 | スミスクライン・ビーチャム・コーポレイション | Sulfonamide |
US6743796B2 (en) | 2001-05-07 | 2004-06-01 | Wyeth | Piperazinyl-isatins |
AR033879A1 (en) | 2001-05-07 | 2004-01-07 | Smithkline Beecham Corp | SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, ITS USE TO PREPARE SUCH COMPOSITION AND PROCEDURE FOR OBTAINING SUCH COMPOUND |
US20040198979A1 (en) * | 2001-05-07 | 2004-10-07 | Dashyant Dhanak | Sulfonamides |
GB0111186D0 (en) * | 2001-05-08 | 2001-06-27 | Smithkline Beecham Plc | Novel compounds |
NZ528450A (en) | 2001-05-11 | 2006-02-24 | Biovitrum Ab | Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders |
US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
RS88803A (en) * | 2001-05-11 | 2007-02-05 | Biovitrum Ab., | Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders |
JP4187642B2 (en) | 2001-06-07 | 2008-11-26 | エフ.ホフマン−ラ ロシュ アーゲー | Novel indole derivatives having 5-HT6 receptor affinity |
EA008476B1 (en) * | 2001-06-11 | 2007-06-29 | Биовитрум Аб | Substituted sulfonamide compounds, process for their use as medicaments for the treatment of cns disorders, obesity and type ii diabetes |
ES2268113T3 (en) | 2001-06-15 | 2007-03-16 | F. Hoffmann-La Roche Ag | DERIVATIVES OF 4-PIPERAZINYLINDOL WITH AFFECTION TO THE RECEIVER 5-HT6. |
US6727264B1 (en) | 2001-07-05 | 2004-04-27 | Synaptic Pharmaceutical Corporation | Substituted anilinic piperidines as MCH selective antagonists |
JP2005527463A (en) * | 2001-08-07 | 2005-09-15 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 3-Arylsulfonyl-7-piperazinyl-indole, -benzofuran and -benzothiophene with 5-HT6 receptor affinity for treating CNS diseases |
ES2316619T3 (en) | 2001-08-10 | 2009-04-16 | F. Hoffmann-La Roche Ag | ARILSULFONYL DERIVATIVES WITH 5-HT RECEPTING AFFINITY 6. |
DE60223936D1 (en) * | 2001-09-05 | 2008-01-17 | Eisai R&D Man Co Ltd | MEANS FOR EXCITING APPETITE AND AGENT FOR TREATING ANOREXIA |
SE0103644D0 (en) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic isoquinoline compounds |
JP2005511594A (en) * | 2001-11-09 | 2005-04-28 | ビオヴィトルム・アクチボラゲット | Use of sulfonamide derivatives in the treatment of obesity or for reducing food intake |
US7094792B2 (en) | 2001-11-22 | 2006-08-22 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
EA200400708A1 (en) | 2001-11-22 | 2004-10-28 | Биовитрум Аб | INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1 |
EP1453514B1 (en) * | 2001-11-30 | 2007-07-18 | F. Hoffmann-La Roche Ag | Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
BR0307429A (en) * | 2002-02-05 | 2004-12-28 | Novo Nordisk As | Compound, use thereof, pharmaceutical composition, and method for treating h3 histamine receptor related disorders or diseases |
EP1471912A1 (en) * | 2002-02-05 | 2004-11-03 | Glaxo Group Limited | Method of promoting neuronal growth |
JP2005526724A (en) * | 2002-02-13 | 2005-09-08 | グラクソ グループ リミテッド | Benzenesulfonamide derivatives as antipsychotic agents |
DE60304695T2 (en) * | 2002-02-13 | 2006-09-21 | Glaxo Group Ltd., Greenford | 7-ARYLSULFONAMIDO-2,3,4,5-TETRAHYDRO-1H-BENZO [D] AZEPINE DERIVATIVES WITH 5-HAT-6-RECEPTOR AFFINITY FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM |
EP1495004A2 (en) * | 2002-02-13 | 2005-01-12 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
JP4455064B2 (en) * | 2002-03-27 | 2010-04-21 | グラクソ グループ リミテッド | Quinoline derivatives and their use as 5-HT6 ligands |
US20040142948A1 (en) * | 2002-05-07 | 2004-07-22 | Dashyant Dhanak | Sulfonamides |
UA76877C2 (en) * | 2002-05-13 | 2006-09-15 | Ф.Хоффманн-Ля Рош Аг | Benzoxazine derivatives as 5-НТ6 modulators anD use thereof |
MXPA04012914A (en) * | 2002-06-20 | 2005-03-31 | Biovitrum Ab | New compounds useful for the treatment of obesity, type ii diabetes and cns disorders. |
JP4754821B2 (en) * | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | Novel compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
EP1897881A3 (en) | 2002-06-20 | 2009-03-18 | Biovitrum AB (publ) | Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
ES2274285T3 (en) | 2002-10-18 | 2007-05-16 | F. Hoffmann-La Roche Ag | 4-PIPERANZINILBENCENOSULFONILINDOLES WITH AFFINITY TO THE RECEIVER 5-HT6. |
AU2003295408A1 (en) * | 2002-11-06 | 2004-06-03 | Smithkline Beecham Corporation | Sulfonamides |
WO2004043369A2 (en) * | 2002-11-06 | 2004-05-27 | Smithkline Beecham Corporation | Sulfonamides |
US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
US20060257613A1 (en) * | 2003-02-13 | 2006-11-16 | Horst Berneth | Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
EP2415760A3 (en) * | 2003-02-20 | 2012-02-22 | Encysive Pharmaceuticals, Inc. | CCR-9 antagonists |
TWI289141B (en) * | 2003-03-11 | 2007-11-01 | Hoffmann La Roche F. Ag. | Quinolinone derivatives and uses thereof |
US7262197B2 (en) * | 2003-03-31 | 2007-08-28 | Janssen Pharmaceutica, N.V | Phospholipase C inhibitors for use in treating inflammatory disorders |
US6946466B2 (en) * | 2003-04-10 | 2005-09-20 | Schering Ag | Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
US20040204422A1 (en) * | 2003-04-14 | 2004-10-14 | Abbott Gmbh & Co. Kg. | N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
ATE313532T1 (en) | 2003-07-22 | 2006-01-15 | Arena Pharm Inc | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONINE RECEPTOR, SUITABLE FOR THE PROPHYLAXIS AND TREATMENT OF RELATED DISEASES |
GB0320320D0 (en) * | 2003-08-29 | 2003-10-01 | Glaxo Group Ltd | Novel compounds |
US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
SE0303480D0 (en) | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
KR20060127886A (en) * | 2003-12-19 | 2006-12-13 | 바이오비트럼 에이비 | Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
AR053407A1 (en) | 2004-07-28 | 2007-05-09 | Glaxo Group Ltd | PIPERAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF SUCH COMPOUND AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT. |
RU2420318C2 (en) * | 2004-09-30 | 2011-06-10 | Ф.Хоффманн-Ля Рош Аг | Compositions and methods for treating cognitive disorders |
EP1812389B1 (en) | 2004-10-14 | 2011-08-17 | Abbott GmbH & Co. KG | Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
CA2583983C (en) | 2004-10-14 | 2013-07-16 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
WO2006062481A1 (en) * | 2004-12-09 | 2006-06-15 | Biovitrum Ab | New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders . |
EP1676841A1 (en) * | 2004-12-30 | 2006-07-05 | Esteve Laboratorios Dr. Esteve S.A. | Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments |
KR100931928B1 (en) * | 2005-01-12 | 2009-12-15 | 인제대학교 산학협력단 | Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease |
CN103110635A (en) | 2005-07-04 | 2013-05-22 | 海波因特制药有限责任公司 | Histamine H3 receptor antagonist |
NZ566495A (en) | 2005-08-12 | 2010-06-25 | Suven Life Sciences Ltd | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
KR101250820B1 (en) | 2005-08-16 | 2013-04-04 | 수벤 라이프 사이언시스 리미티드 | An improved process for the preparation of losartan |
US20100048713A1 (en) * | 2006-01-06 | 2010-02-25 | Aarhus Universitet | Compounds acting on the serotonin transporter |
TW200808709A (en) | 2006-03-31 | 2008-02-16 | Glaxo Group Ltd | Novel compounds |
CA2648892A1 (en) | 2006-04-19 | 2007-10-25 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
BRPI0710177A2 (en) | 2006-04-19 | 2012-05-29 | Abbott Gmbh & Co Kg | heterocyclic arylsulfones suitable for treating disorders responsive to serotonin 5ht6 receptor modulation |
EP2038256A1 (en) | 2006-05-23 | 2009-03-25 | TransTech Pharma, Inc | 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament |
EA016026B1 (en) | 2006-05-29 | 2012-01-30 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
EP2086329B1 (en) * | 2006-10-26 | 2014-07-23 | The Arizona Board of Regents on behalf of the University of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
WO2008084492A1 (en) | 2007-01-08 | 2008-07-17 | Suven Life Sciences Limited | 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
MX2009007416A (en) * | 2007-01-10 | 2009-07-17 | Hoffmann La Roche | Sulfonamide derivatives as chymase inhibitors. |
AU2008231789A1 (en) | 2007-03-23 | 2008-10-02 | Abbott Gmbh & Co. Kg | Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
MX2009011461A (en) | 2007-05-03 | 2009-11-10 | Suven Life Sciences Ltd | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands. |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
ES2359170T3 (en) * | 2007-07-19 | 2011-05-19 | Laboratorios Del Dr. Esteve S.A. | TETRAHIDRO-QUINOLÍN-SULFONAMIDA SUBSTITUTED COMPOUNDS, THEIR PREPARATION AND USE AS MEDICINES. |
CA2703157C (en) | 2007-10-26 | 2013-02-05 | Suven Life Sciences Limited | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
PA8802201A1 (en) * | 2007-11-02 | 2009-06-23 | Abbott Gmbh & Co Kg | APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR |
WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
WO2009128058A1 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
WO2009152356A2 (en) * | 2008-06-11 | 2009-12-17 | Irm Llc | Compounds and compositions useful for the treatment of malaria |
WO2010032257A1 (en) | 2008-09-17 | 2010-03-25 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands |
EA019496B1 (en) | 2008-09-17 | 2014-04-30 | Сувен Лайф Сайенсиз Лимитед | Aryl sulfonamide amine compounds and their use as 5-htligands |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
UA100192C2 (en) | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
KR101073703B1 (en) | 2009-04-07 | 2011-10-14 | 한국화학연구원 | Piperazine derivatives, pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of central nervous system diseases containing the same as an active ingredient |
US8343959B2 (en) | 2009-04-30 | 2013-01-01 | Abbott Gmbh & Co. Kg | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
WO2010125134A1 (en) | 2009-04-30 | 2010-11-04 | Abbott Gmbh & Co. Kg | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
JP2012525356A (en) * | 2009-04-30 | 2012-10-22 | アボット ゲーエムベーハー ウント カンパニー カーゲー | Benzenesulfonanilide compounds suitable for treating disorders responsive to modulation of serotonin 5-HT6 receptors |
EP2424844A1 (en) * | 2009-04-30 | 2012-03-07 | Abbott GmbH & Co. KG | Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
KR101463190B1 (en) | 2010-01-05 | 2014-11-18 | 수벤 라이프 사이언시스 리미티드 | Sulfone compounds as 5-HT6 receptor ligands |
KR101871011B1 (en) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
ES2413911B1 (en) * | 2011-12-15 | 2014-05-14 | Universidad De Zaragoza | INHIBITING AGENT OF THE AGGREGATION OF THE BETA AMILOID PEPTIDE. |
CN104220421A (en) | 2012-03-20 | 2014-12-17 | 阿达梅德公司 | Sulphonamide derivatives of benzylamine for the treatment of cns diseases |
RU2019119893A (en) | 2013-03-14 | 2019-08-09 | Толеро Фармасьютикалз, Инк. | JAK2 AND ALK2 INHIBITORS AND WAYS TO USE THEM |
AU2013394970B2 (en) | 2013-07-25 | 2017-11-23 | Centre National De La Recherche Scientifique | Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof |
CN105085436B (en) | 2014-04-19 | 2019-08-16 | 广东东阳光药业有限公司 | Sulfonic acid amide derivatives and its application on drug |
CN105367473B (en) * | 2014-08-12 | 2020-02-11 | 广东东阳光药业有限公司 | Indoline derivative and application thereof in medicine |
CN105367472B (en) * | 2014-08-12 | 2020-04-21 | 广东东阳光药业有限公司 | Indoline derivative and application thereof in medicine |
UA126268C2 (en) | 2015-01-06 | 2022-09-14 | Арена Фармасьютікалз, Інк. | Methods of treating conditions related to the s1p1 receptor |
WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
EA201890096A1 (en) | 2015-06-22 | 2018-08-31 | Арена Фармасьютикалз, Инк. | CRYSTALLINE L-ARGININE SALT (R) -2- (7- (4-CYCLOPENTHYL-3- (TRIFTLOMETHYL) BENZYLOXY) -1,2,3,4-TETRAHYDROCYCLOPENT [b] INDOL-3-IL) ACETIC ACID ) FOR APPLICATION IN DISORDERS RELATED TO S1P RECEPTOR |
CN108472285A (en) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | Diaryl for preventing and treating illusion associated with neurodegenerative disease and aryl heteroaryl urea derivative |
CN108926565A (en) * | 2017-05-26 | 2018-12-04 | 中国科学院上海生命科学研究院 | The application of 6 small molecule activators of serotonin receptor subtype and antagonist in prevention and treatment Alzheimer's disease |
WO2019180176A1 (en) | 2018-03-21 | 2019-09-26 | Spherium Biomed, S.L. | Composition for the treatment of schizophrenia and/or psychosis |
AU2019310590A1 (en) | 2018-07-26 | 2021-01-14 | Sumitomo Pharma Oncology, Inc. | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE81861C (en) | ||||
NZ193654A (en) * | 1979-05-16 | 1984-08-24 | Wuelfing Johann A | Naphthalene sulphonamido-alkyl-piperidines,pyrrolidines or piperazines and pharmaceutical compositions |
US4315014A (en) * | 1980-09-24 | 1982-02-09 | Warner-Lambert Company | Antibacterial amide compounds and pharmaceutical composition containing the same |
DE3276313D1 (en) * | 1981-09-24 | 1987-06-19 | Beecham Wuelfing Gmbh & Co Kg | Sulphonamides |
CN85106905A (en) * | 1985-08-08 | 1987-02-04 | Fmc公司 | Contain 1-aryl-Δ 2-1,2,4, weedicide of-triazoline-5-ketone and preparation method thereof |
AU5175490A (en) * | 1989-02-27 | 1990-09-26 | Du Pont Merck Pharmaceutical Company, The | Novel sulfonamides as radiosensitizers |
JPH04330057A (en) * | 1991-05-01 | 1992-11-18 | Hiroyoshi Hidaka | Anilinearylsulfonic acid amides and acid addition salt thereof allowable as medicine |
GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
DE4206531A1 (en) * | 1992-03-02 | 1993-09-09 | Bayer Ag | N-ARYL NITROGEN HETEROCYCLES |
DE4303376A1 (en) * | 1993-02-05 | 1994-08-11 | Bayer Ag | Substituted triazolinones |
DE69417427T2 (en) * | 1993-09-03 | 1999-11-25 | Smithkline Beecham P.L.C., Brentford | INDOL AND INDOLIN DERIVATIVES AS 5HT1D RECEPTOR ANTAGONISTS |
EP0724580A1 (en) * | 1993-10-19 | 1996-08-07 | Smithkline Beecham Plc | Benzanilide derivatives as 5ht-1d receptor antagonists |
JPH09506101A (en) * | 1993-12-07 | 1997-06-17 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Heterocyclic biphenylylamides useful as 5HT1D antagonists |
EP0763034A1 (en) * | 1994-05-28 | 1997-03-19 | Smithkline Beecham Plc | Amide derivatives having 5ht1d-antagonist activity |
US5939451A (en) | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
DZ2376A1 (en) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them. |
-
1997
- 1997-12-07 DZ DZ970226A patent/DZ2376A1/en active
- 1997-12-15 EA EA199900561A patent/EA002351B1/en not_active IP Right Cessation
- 1997-12-15 SK SK808-99A patent/SK80899A3/en unknown
- 1997-12-15 PL PL97334337A patent/PL334337A1/en unknown
- 1997-12-15 BR BR9713734-0A patent/BR9713734A/en not_active IP Right Cessation
- 1997-12-15 IL IL13029797A patent/IL130297A0/en unknown
- 1997-12-15 KR KR1019997005497A patent/KR20000069554A/en not_active Application Discontinuation
- 1997-12-15 AP APAP/P/1999/001556A patent/AP1277A/en active
- 1997-12-15 WO PCT/EP1997/007159 patent/WO1998027081A1/en not_active Application Discontinuation
- 1997-12-15 AU AU60904/98A patent/AU729056B2/en not_active Ceased
- 1997-12-15 DE DE69724142T patent/DE69724142T2/en not_active Expired - Fee Related
- 1997-12-15 CZ CZ992203A patent/CZ220399A3/en unknown
- 1997-12-15 AT AT97954929T patent/ATE247099T1/en not_active IP Right Cessation
- 1997-12-15 HU HU0000658A patent/HUP0000658A3/en unknown
- 1997-12-15 CA CA002275492A patent/CA2275492A1/en not_active Abandoned
- 1997-12-15 EP EP97954929A patent/EP0946539B1/en not_active Expired - Lifetime
- 1997-12-15 CN CN97181816A patent/CN1246116A/en active Pending
- 1997-12-15 NZ NZ335970A patent/NZ335970A/en unknown
- 1997-12-15 ES ES97954929T patent/ES2203831T3/en not_active Expired - Lifetime
- 1997-12-15 ID IDW990546A patent/ID22821A/en unknown
- 1997-12-15 TR TR1999/01361T patent/TR199901361T2/en unknown
- 1997-12-15 JP JP52734798A patent/JP2001506646A/en not_active Ceased
- 1997-12-17 PE PE1997001126A patent/PE46899A1/en not_active Application Discontinuation
- 1997-12-17 MA MA24902A patent/MA24426A1/en unknown
- 1997-12-17 AR ARP970105951A patent/AR010795A1/en not_active Application Discontinuation
- 1997-12-18 TW TW086119136A patent/TW418205B/en not_active IP Right Cessation
- 1997-12-18 UY UY24819A patent/UY24819A1/en not_active Application Discontinuation
-
1999
- 1999-06-18 NO NO993003A patent/NO993003D0/en not_active Application Discontinuation
- 1999-06-18 OA OA9900133A patent/OA11066A/en unknown
- 1999-06-25 BG BG103530A patent/BG103530A/en unknown
-
2000
- 2000-08-21 US US09/643,200 patent/US6423717B1/en not_active Expired - Fee Related
-
2002
- 2002-05-29 US US10/157,258 patent/US6599904B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL334337A1 (en) | Derivatives of sulphonamides, method of obtaining them and their application as drugs | |
PL318277A1 (en) | Novel substituted axazolydinones, method of obtaining and drugs containing them | |
PL321003A1 (en) | Derivatives of piperasine, drugs containing them, their application and methods of obtaining them | |
PL314635A1 (en) | Derivatives of pyrimidinodione, pyrimidinotrione, triazinodione and tetrahydroquinazolinodione and method of obtaining them | |
PL318278A1 (en) | Novel heteroaryl oxazolydinones, method of obtaining and drugs containing them | |
PL338143A1 (en) | Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them | |
PL317929A1 (en) | Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them | |
PL328608A1 (en) | Novel derivatives of erythromycin, method of obtaining them and their therapeutic application as drugs | |
PL312270A1 (en) | Novel derivatives of indolopiperidine, method of obtaining them and pharmaceutical preparation and method of obtaining same | |
PL317071A1 (en) | Novel derivatives of erythromycin, method of obtaining them and their application as medical agents | |
AU3028897A (en) | New guanidine derivatives, methods of preparing them, and their use as drugs | |
PL310038A1 (en) | Glycinamide derivatives, methods of obtaining them and drugs containing such derivatives | |
PL321201A1 (en) | Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives | |
PL316816A1 (en) | Derivatives of purin-6-one, method of obtaining them and drugs containing such derivatives | |
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
AP9400706A0 (en) | Indole derivatives, method of preparation and use | |
PL331344A1 (en) | Acryloyl-substituted derivatives of distamycin, method of obtaining them and their application as anticarcinogenic and antiviral agents | |
PL329878A1 (en) | Derivatives of distamycin, method of obtaining them and their application as anticarcinogenic and antiviral agents | |
PL323177A1 (en) | Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes | |
HUP9902311A3 (en) | New triazolopurines, method of preparing them and their use as drugs | |
PL323673A1 (en) | Derivatives of oxazolydinone, method of obtaining them and their pharmaceutic application | |
PL331287A1 (en) | Substituted derivatives of pyrazoyl-pyrazole, method of obtaining them and their application as herbicides | |
PL329213A1 (en) | Novel derivatives of diarylmethylidene furane, method of obtaining them and their therapeutic application | |
HUP0001773A3 (en) | Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them | |
PL342453A1 (en) | Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs |